News Releases December 6, 2021 Ventyx Biosciences Announces First Patient Dosed in a Phase 2 Clinical Trial of VTX002 for the Treatment of Moderate-to-Severe Ulcerative Colitis Read more November 19, 2021 Ventyx Biosciences to Participate in Two Upcoming Investor Conferences Read more November 17, 2021 Ventyx Biosciences Reports Third Quarter Financial Results and Provides Business Update Read more October 25, 2021 Ventyx Biosciences Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares Read more October 20, 2021 Ventyx Biosciences Announces Pricing of Upsized Initial Public Offering Read more September 20, 2021 Ventyx Biosciences Announces Key Appointments and Closing of $51.0 Million Series B Convertible Preferred Stock Financing Round Read more First page « Previous page ‹ Page 1 Page 2 Current page 3 Displaying 21 - 26 of 26
